Form 4: Harmony Biosciences Director Antonio J. Gracias Acquires Stock Options

Director Antonio J. Gracias acquired 14,522 stock options in Harmony Biosciences Holdings, Inc. on May 15, 2025.

Summary

• On May 15, 2025, Antonio J. Gracias, a director of Harmony Biosciences Holdings, Inc., acquired 14,522 stock options.
• The exercise price of these options is $34.23.
• The options vest in full on the earlier of May 15, 2026, or the date of the next annual meeting following the grant date, contingent upon continued service.
• The options expire on May 15, 2035.
• Following the transaction, Gracias directly owns 14,522 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a director generally indicates confidence in the company's future, but it's a routine transaction.

Positives

• A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the stock options is contingent upon continued service, suggesting an expectation of ongoing involvement by the director.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.

Stakeholder Impact

• The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

stock options, Form 4, Harmony Biosciences, Antonio J. Gracias, director, HRMY, acquisition